Drugbank Logo

Search Results

Search for "Zalcitabine" returned 4 results

Showing 1-4 out of 4
DrugBank ID Name Formula Weight
DB00943
DrugCard button for DB00943
Zalcitabine C9H13N3O3 211.2178
Zalcitabine Zalcitabine inhibits the activity of HIV-1 reverse transcriptase (RT) both by competing with the natural substrate dGTP and by its incorporation into viral DNA. PA451950 Less than 4 ...
DB00709
DrugCard button for DB00709
Lamivudine C8H11N3O3S 229.2560
Zalcitabine Lamivudine decreases the efficacy of zalcitabine Take without regard to meals. Food does not decrease the extent of absorption, but it decreases the Cmax by slowing the rate of absorption.
DB00625
DrugCard button for DB00625
Efavirenz C14H9ClF3NO2 315.6750
It is a synthetic purine derivative and, similar to zidovudine, zalcitabine, and stavudine. Efavirenz was originally approved specifically for the treatment of HIV infections in patients who ...
DB00900
DrugCard button for DB00900
Didanosine C10H12N4O3 236.2273
... antiviral agent increases the effect and toxicity of didanosine Zalcitabine Additive toxicities (peripheral neuropathy) Avoid alcohol. Take on empty stomach: 1 hour before or 2 hours after meals.
Showing 1-4 out of 4

This project is supported by Genome Alberta & Genome Canada, a not-for-profit organization that is leading Canada's national genomics strategy with $600 million in funding from the federal government. This project is also supported in part by GenomeQuest, Inc., an enterprise genomic information company serving the life science community.